Priligy FDA Approval Status
FDA Approved: No
Brand name: Priligy
Generic name: dapoxetine
Company: ALZA Corporation
Treatment for: Premature Ejaculation
Priligy (dapoxetine) is a short-acting selective serotonin reuptake inhibitor (SSRI) under review for the treatment of premature ejaculation.
Development timeline for Priligy
| Date | Article |
|---|---|
| Oct 26, 2005 | ALZA Corporation Receives Letter From FDA on Dapoxetine Application |
| Dec 4, 2004 | New Drug Application Submitted for Dapoxetine for Premature Ejaculation |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
